Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy - Poll - MDSpire

Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

  • By

  • Javier Cifuentes-Quin

  • Yiselle T. Garcia-Montañez

  • Alexandra Hurtado-Ortiz

  • Jhonatan Cruz

  • Luis Carlos Lagares

  • Luis A. Olarte-Licht

  • Maricel Licht-Ardila

  • Edgar Fabián Manrique-Hernández

  • May 22, 2026

Share

Original Source(s)

Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

  • by Javier Cifuentes-Quin, Yiselle T. Garcia-Montañez, Alexandra Hurtado-Ortiz, Jhonatan Cruz, Luis Carlos Lagares, Luis A. Olarte-Licht, Maricel Licht-Ardila, Edgar Fabián Manrique-Hernández

  • May 22, 2026

Related Content

Liquid Biopsy Supports Precision Oncology

Experts highlight clinical value, workflow integration, and real-world impact in lung and breast cancer diagnostics

  • May 22, 2026

  • 8 min
The CRISPR-powered Diagnostic SLEUTH

Novel DNA-guided system may support future RNA diagnostics and mutation detection

  • May 22, 2026

  • 2 min
Vibe-Reporting Comes to Omics? 

Jesse Meyer’s vibe-coded app is impressive, says Randall Julian, but don’t call it a “platform”

  • May 22, 2026

  • 4 min